4//SEC Filing
Chacko Jacob 4
Accession 0001608936-25-000014
CIK 0001796280other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:18 PM ET
Size
13.9 KB
Accession
0001608936-25-000014
Insider Transaction Report
Form 4
Chacko Jacob
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-15+83,666→ 615,085 total - Sale
Common Stock
2025-12-16$9.06/sh−33,374$302,368→ 581,711 total - Exercise/Conversion
Restricted Stock Unit
2025-12-15−22,000→ 0 total→ Common Stock (22,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-12-15−28,333→ 28,334 total→ Common Stock (28,333 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-12-15−33,333→ 66,667 total→ Common Stock (33,333 underlying)
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock.
- [F2]Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
- [F3]Represents the weighted average share price of an aggregate total of 33,374 shares sold in the price range of $9.0257 to $9.095 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.
- [F5]1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.
- [F6]1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001608936
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:18 PM ET
- Size
- 13.9 KB